Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(7 sites)

China

The First Hospital of Lanzhou University, Lanzhou, Gansu

Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong

Hainan hospital of Chinese PLA General Hospital, Sanya, Hainan

Jin Yin-tan Hospital, Wuhan, Hubei

Shanghai Changzheng Hospital, Shanghai, Shanghai Municipality